Reuters logo
CORRECTED-BRIEF-Strides Shasun gets USFDA approval for memantine hydrochloride tablets
May 24, 2017 / 5:27 AM / 4 months ago

CORRECTED-BRIEF-Strides Shasun gets USFDA approval for memantine hydrochloride tablets

(Corrects company name in headline to ‘Strides Shasun’ from ‘Strides Ahasun’)

May 24 (Reuters) - Strides Shasun Ltd:

* Says Strides Shasun receives USFDA approval for memantine hydrochloride tablets

* Says product to be launched immediately

* Says product to be manufactured at Bangalore facility and marketed by Strides Pharma Inc in U.S. Market Source text - (bit.ly/2rSh4dG) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below